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Agent-based models have been employed to describe numerous processes in immunology. Simula-
tions based on these types of models have been used to enhance our understanding of immunology
and disease pathology. We review various agent-based models relevant to host-pathogen systems
and discuss their contributions to our understanding of biological processes. We then point out some
limitations and challenges of agent-based models and encourage efforts towards reproducibility and
model validation.
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I. INTRODUCTION
The ideas gleaned from studying immunology and
host-pathogen systems may be relevant not only to hu-
man health but also to a wide array of other systems. A
pathogen is any infectious agent that can lead to illness or
disease of a host. Examples of pathogens include human
immunodeficiency virus (HIV),Mycobacterium tuberculo-
sis, the etiological agent for tuberculosis, the SARS coro-
navirus, and the influenza virus. In these cases, the host
is usually a human being or an animal. However, in gen-
eral terms, a host could just as easily be a computer net-
work and the pathogen a computer virus. The immune
system has memory and learns about the pathogens it
encounters. It also must discriminate between self and
non-self. Consequently, applications of the ideas intuited
from immune system dynamics can be translated into
algorithms relevant to learning, pattern discrimination,
artificial intelligence adaptive behavior, and applied to-
wards goals such as the development of new computer
virus security applications [39, 40, 48, 49, 55, 62, 86].
The interested readers should see [38].
Because of the difficulty in reasoning about large num-
bers of interacting components with non-linear interac-
tions, mathematical modeling and simulation are becom-
ing important research tools. Depending on what aspect
of the host-pathogen system is being investigated, differ-
ent mathematical modeling tools are employed. Below
we discuss several modeling techniques commonly used
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to describe such systems.
Ordinary differential equation (ODE) models are of-
ten used as a starting point to describe host-pathogen
systems. One of the advantages of using ODEs is that
a lot is known about their behavior. ODE models are
simple and elegant and require fewer parameters than
their spatial counterparts (e.g., agent-based models or
partial differential equations). This is an important con-
sideration when experimental data is obtained from a
well-mixed compartment, such as blood, or from a ho-
mogenate of a tissue, such as the spleen or lymph node,
where spatial information is lacking. For example, in a
recent model of influenza infection in humans, Baccam
et al. [5] used an ODE model not because the body
is well-mixed but due to the fact that the data being
analyzed was the amount of virus in nasal wash. When
sufficiently simple, ODEs have the added benefit of being
analytically tractable, and techniques such as bifurcation
theory can be used to predict, for example, parameter
values that switch a system from pathogen clearance to
a chronically infected state. There are, however, limita-
tions to using ODE models. These models assume that
the populations (dependent variables) are homogeneous
and uniformly distributed over the simulation space for
all time. This is an assumption that may not be real-
istic, and that may significantly influence the resulting
dynamics. To examine the effects of the assumption of
spatial homogeneity, there is a growing body of research
probing the effects of spatial distribution on systems in
ecology [32, 33, 107], epidemiology [45, 63], and immunol-
ogy [10, 41, 64, 97]. One option to address this limitation
is to use partial differential equations (PDEs), which cap-
ture changes in both time and space, but, in general, as
these equations get more complicated, and consequently
more computationally challenging, the advantages to us-
ing PDE models wane. For both ODE and PDE models,
2one must also consider that solutions to these equations
only provide an average or mean field description of the
system behavior with little or no information about the
possible deviations from this aggregated behavior.
An alternative to differential equation models are
agent-based models (ABMs). ABMs are stochastic mod-
els used to describe populations of interacting agents,
such as insects and people, using simple rules that dic-
tate their behaviors. These models were originally intro-
duced by John von Neumann and Stanislaw Ulam under
the name of “cellular spaces” as a possible idealization of
biological systems. They sought to show that biological
processes such as the reproduction and evolution of or-
ganized forms could be modeled by simple cells following
local rules [46]. A well known feature of ABMs is their
ability to generate surprisingly complex and emergent
behavior from very simple rules, including periodic be-
haviors or intricate spatial and temporal patterns [106].
Agent actions are asynchronous, that is, they do not
evolve at constant time steps. Instead, agents respond
dynamically and independently to changing environmen-
tal or discrete event cues. Consequently, nonlinearities
and time-delays are not difficult to treat empirically since
they can be incorporated into the agent’s rules or they
may even emerge naturally as a consequence of the sys-
tem’s collective dynamics. Another advantage to ABMs
is that their computational structure is inherently par-
allel and therefore can be implemented on parallel com-
puters very efficiently.
In this article, we review a variety of agent-based mod-
eling approaches and their contributions to our under-
standing of host-pathogen interactions and disease dy-
namics.
II. APPLICATIONS OF AGENT-BASED
MODELS
Agent-based models are quickly gaining in popularity.
As experimental assays are developed that increase our
understanding of host-pathogen interactions, the level of
description desired for realistic and relevant models is
increasingly more complex. Computer processing is be-
coming faster and more efficient, expanding the compu-
tational ability of computers and making possible the
use of ABMs for complex systems. Moreover, because
ABM implementation is achieved at the agent level, the
description of the agents and rules tends to mimic the
language used to describe the real system, that is, the
description is more physical in character than mathe-
matical. For example, models using differential equations
consider rates of creation, rates of death, rates of bind-
ing, or rates of diffusion for whole populations of agents,
whereas an ABM considers the rules guiding the actions
of the agent. The familiar and natural modeling language
used in agent based models not only makes ABMs ap-
proachable and useful to experimentalists and clinicians,
but also engages them in the modeling process.
A. ABMs as Immune System and Disease
Simulators
A number of immune simulators have been constructed
that provide a programming framework that in principle
could incorporate all current knowledge of immunology
and could be used to model any aspect of immune dynam-
ics. Platforms like IMMSIM [7, 16, 17, 22, 23, 24, 57, 58,
89], SIMMUNE [68, 69], Reactive Animation [34, 35, 36],
and SIS [26, 60, 67] are true immune simulators and al-
low users to define the rules of interactions and simulate
an immune reaction. Most of the immune simulators are
developed to make the interaction rules simple to define
and easy to change in order to facilitate the exploration
and impact of different rules on the development and out-
come of an immune response. Some of these simulators
are more flexible than others. With IMMSIM, for exam-
ple, one would typically tune interactions by changing
parameter values and one could, for example, completely
turn off the humoral response by setting to zero the right
set of parameters [58]. With a system like Reactive Ani-
mation, users can potentially go even further and choose
between what the authors refer to as “running theories”
[34]. When the rules of interactions between, for exam-
ple, an epithelial cell and a T cell are not known there
typically exist various hypotheses for the way in which
such interactions proceed. The Reactive Animation sys-
tem would allow the user to choose between different hy-
potheses and observe the impact of that choice on the
simulation dynamics.
The usefulness and applicability of these simulators
vary, but some have been applied to important immuno-
logical problems and their findings published in exper-
imental journals. For example, IMMSIM was used to
model affinity maturation and hypermutation in the hu-
moral immune system [23], to test approaches to vac-
cine design [58], and to investigate mechanisms for tol-
erance to pathologic rheumatoid factors [96]. IMMSIM
has also been used as a pedagogical tool: Prof. Mar-
tin Weigert used IMMSIM in his seminar “Why Immune
Systems Fail: Autoimmunity, Influenza Pandemics and
HIV” at Princeton to demonstrate rather than just de-
scribe immune cell interactions [87]. SIMMUNE became
the cornerstone of the Program in Systems Immunol-
ogy and Infectious Disease Modeling (PSIIM) at the Na-
tional Institute of Allergy and Infectious Diseases [8],
a program dedicated to the use of computational ap-
proaches to problems in immunology. Recently, immu-
nologist Ronald N. Germain, in collaboration with SIM-
MUNE’s creator, Martin Meier-Schellersheim, and oth-
ers used the simulator to investigate the mechanism of
chemo-sensing [70].
Another type of simulator, which we refer to as a dis-
ease simulator, is a general programing framework that
can be tuned to model a specific disease including tu-
mor growth, tuberculosis, or influenza. By changing pa-
rameters, such as the rate of spread of the infection,
the lifespan of infected cells, or the binding rates of cy-
3tokines, users can calibrate these frameworks to model
a variety of diseases. Three such simulators are CyCells
[102, 103, 104, 105], PathSim [85, 90] and the MASyV
modules ma immune and ma virions [10, 11, 13]. These
simulators reproduce a variety of host-pathogen interac-
tions, and are typically easier to use and calibrate than
the immune simulators.
In contrast to general disease simulators, there is an-
other class of ABMs that concentrates instead on a sin-
gle disease or on specific aspects of immune mechanisms.
Among these are models of: HIV [97, 109], M. tubercu-
losis [88, 102], Epstein-Barr [31, 90], influenza [13, 14],
cancer vaccination [78, 79], tumor growth and invasion
[1, 53, 65, 108], tumor-induced angiogenesis [9], and
acute inflammation [2, 4]. Some of these simulators have
greatly contributed to improving our understanding of
the dynamics of a disease and represent novel and origi-
nal approaches to modeling.
B. The Use of Agent-Based Models by
Experimentalists
The appeal of ABMs is such that their use goes beyond
the realm of traditional modelers. While the involve-
ment of experimentalists in mathematical modelling re-
mains somewhat limited, ABMs in immunology/disease
modeling have engaged experimentalists since their be-
ginning. Indeed, one of the first ABM of immune in-
teractions, IMMSIM, was the result of a close collabora-
tion between Philip E. Seiden, a computer scientist, and
Franco Celada, a well-respected experimentalist. This
is a testament to the appeal of ABMs, where the de-
scription and representation of disease systems are close
to that of the true biological system. This attraction
for experimentalists is helping to bridge the gap between
theoretical models and experiments.
Marc Jenkins of the University of Minnesota is one
such experimentalist. New imaging methods have, for
the first time, permitted the visualization of individual T
cells and their interactions with antigen-presenting cells
in vivo [6, 42, 71, 74]. Jenkins and his team assembled
the emerging literature into a coherent picture of the first
50 hours of a primary immune response to an antigen in
the form of an animation [21]. Their model, or rather
their animation, was implemented as a movie simula-
tion using Macromedia Flash MX. It consists of a two-
dimensional plane, which corresponds to a 10 µm slice
(approximately one cell diameter) through a hypothetical
spherical lymph node 2 mm in diameter, and includes T
cells, B cells, and dendritic cells. Random motion paths
for each cell in the simulation are pre-scripted individu-
ally and scaled to their known approximate speeds taken
from the two-photon microscopy literature [73, 76]. Re-
strictions are put on the paths, such that B cells are
confined to the follicles (except 5 hours after exposure to
antigen when their movement is restricted to the outer
edge of the follicles near the T cell area), dendritic cells
to the T cell area, and T cells to the T cell area and outer
edges of the follicles for 90% and 10% of their paths, re-
spectively. When a collision occurs between two cells, the
cells’ motion along their respective path is halted for a
defined amount of time to mimic real-time interactions.
The time alloted to each interaction depends on the cir-
cumstances. The restrictions on the cell paths and the
scripted interaction times were all taken from published
experimental results.
Jenkins’ approach is novel; rather than writing what
they feel would be a good model at an appropriate level
of detail and then seeking empirical data to calibrate the
model, their model was built piece by piece from the
experimental literature. The resulting simulation consti-
tutes a very complete and convincing visual summary of
the available knowledge at the time and is exemplary of
the capability of ABMs to translate and synthesize a large
body of compartmentalized research on a complex bio-
logical system. Moreover, movies of Jenkins’ simulations
make other important biological contributions. For ex-
ample, these movies showed that it is possible to have B-
T cell interactions in the absence of directed cell chemo-
taxis. Indeed, random mechanisms based on restriction
of B cells to a specific spatial area rarely patrolled by
T cells can also result in T-B cell interactions if T cells
proliferate first, thus increasing the probability of a T-B
cell encounter [21].
Another experimentalist seduced by the appeal of
ABMs is Gary An, an M.D. in Trauma and Critical Care
at Northwestern University Feinberg School of Medicine.
Dr. An employed agent-based modeling to describe sys-
temic inflammatory response syndrome and multiple or-
gan failure [3, 4], the first application of agent-based
modeling to critical care. An important aspect of this on-
going work is the utilization of agent-based modeling to
simulate clinical trials, providing a crucial link between
theoretical modeling and the clinical setting [2]. This
model assumes that the primary immune response is initi-
ated by endothelial cell injury at the cell-blood boundary
and that the inflammatory response is translated from a
local response to a systemic one. Model agents are en-
dothelial cells, neutrophils, monocytes, several popula-
tions of T helper cells, and neutrophil/monocyte/T lym-
phocyte progenitor cells. The model also considers the
role of a number of cell receptors, including the ICAM,
IL-1, and TNF-α receptors, and relevant chemical medi-
ators. Compared with results from other clinical trials
and animal studies, this model reproduced the general
behavior of the innate inflammatory response as mea-
sured by patient outcome and cause of death. In silico
trials of anti-cytokine therapy were simulated and com-
pared qualitatively well with those in published phase III
anti-cytokine clinical trials. Dr. An then formulated a
series of hypothetical treatment strategies and used his
model to evaluate the efficacy of the proposed interven-
tions. Even this relatively simple ABM of the immune
response displays complex and counter-intuitive system
dynamics. Conceptually, the use of ABMs to simulate
4clinical trials holds a great deal of promise and sets the
stage for other theoreticians and experimentalists to use
models to formulate and test treatment strategies before
commencing actual animal or human trials.
C. Studying Localized Spatial Effects
ABMs are stochastic models; as such they can reveal
unique dynamics resulting from very specific spatial con-
figurations or from rare localized events that would be
missed using a mean field approach. This is a particularly
valuable feature of these types of models, especially since
similar features are responsible for variations seen in the
development and outcome of infection in different indi-
viduals or in a given individual at different times. Many
papers have investigated the effects of varying spatial
configurations or the occurrence of rare localized events
on infections [10, 41, 64, 97].
Louzoun et al. [64] investigated the effects of spatial
heterogeneity of antigen concentration on lymphocyte
proliferation. First, the authors define a simple system
with two species: antigen and lymphocytes. The anti-
gen population grows at a constant rate and decays at
a rate proportional to its concentration. Lymphocytes
grow at a rate proportional to both their concentration
and to the concentration of antigen, and die at a rate
proportional to their concentration. For this model, the
authors showed that if the concentration of antigen was
above some threshold, the lymphocytes would proliferate,
otherwise they would not. The authors then discretized
the antigen and lymphocyte populations in both space
and time, and incorporated the discrete addition or re-
moval of agents (lymphocytes or antigen) with a given
probability rather than at a given rate. This change re-
sulted in the emergence of local hot spots of lymphocyte
proliferation. So while the average antigen concentration
was not above the threshold required for lymphocyte pro-
liferation, regions where the local antigen concentration
was above the threshold quickly dominated the system
average with a growth rate proportional to the peaks of
local concentration of antigen, and not to the average
concentration throughout the system [64].
Strain et al. [97] examined the specific case of an HIV
infection and compared the behavior of a commonly used
ODE model [81, 82] to an analogous cellular automaton
model where each lattice site represents a T cell. From
the diffusion rate of virions and the rate of encounter and
fusion between virus and T cells, the authors derived an
expression for the probability that a T cell located a cer-
tain distance away from a bursting infected T cell will
become infected. The authors initiate their simulation
with a single infected cell which in turn infects other cells
according to the probability they derived. Subsequent
infections result in a radial wave of infection moving out-
ward. This wave leaves behind a pool of infected cells. If
the replacement rate of dead cells with new target cells
is slow, the wave dissipates and uninfected cells replenish
the area. If the replacement rate is fast, the newly regen-
erated target cells cause the infection wave to recede and
a chaotic steady state pattern forms [97]. Most impor-
tantly, because infectivity depends on the concentration
of T cells (neighbors can be infected more readily when
cells are tightly packed), the authors found that the ODE
model overestimated viral infectiousness by more than
an order of magnitude when compared with the spatial
model [97].
Funk et al. [41] used an approach similar to that of
Louzoun et al. [64], but proposed a more complete and
realistic model of three species: uninfected target cells,
virus-infected cells, and virus. The authors first present
the dynamics of the non-spatial homogeneous model, and
then extend the model to a 2-D spatial model, and fi-
nally they randomly vary the parameters from site to site
according to a uniform distribution. Comparing results
from the non-spatial homogeneous model with the spatial
model, the authors found that as the infection spreads
outwards from the initial infection site, the viral titer
curves for both models are initially similar. However, as
the initially infected sites approach an equilibrium state
and outer cells become affected by the infection wave,
the increase in virus slows. This phenomenon is not seen
in the non-spatial homogeneous model. As in the Strain
et al. model, the Funk et al. spatial models also resulted
in lower average viral concentrations when compared to
non-spatial homogeneous models [41].
When the parameters of the Funk et al. model were
varied from site to site, a new dynamic was revealed.
This new system formed a series of source and sink sites
and the ability of the virus to migrate from site to site
(its diffusion rate) had a significant impact on the dy-
namics. Finally, the authors added immune cells to their
heterogeneous spatial model. For this case, they found
that a spatial model greatly improved the stability of
the infection. Stability was enhanced because the equiv-
alent non-spatial homogeneous model gave rise to large
oscillations, analogous to what is observed in predator-
prey models in ecology. In contrast, the spatial coupling
by local dispersal of virus and immune cells in the non-
homogeneous spatial model resulted in oscillations at dif-
ferent sites that were out of phase. These oscillations
were damped and had the effect of spatially averaging the
dynamics. This is a very interesting finding as the large
long-lasting periods of oscillations commonly observed in
non-spatial models are only very rarely observed exper-
imentally or clinically, while the equalized dynamics of
spatial models are more in line with experimental and
clinical observations.
Finally, Beauchemin [10] investigated the effect of vi-
ral infection spread in tissue and the particular effect
on influenza dynamics. The model is a 2-D square lat-
tice where each site represents a target cell and the grid,
which represents the tissue, is patrolled by generic im-
mune cells which can kill infected cells. While the mod-
els mentioned above all initiate infection with a single
infected cell, this work explored the effect of altering the
5initial distribution of infected cells. The cases examined
included a given number of initial cells distributed either
randomly on the grid, in small isolated groups of several
cells, or as a single lump. Beauchemin found that infec-
tion dynamics was sensitive to the initial spatial distribu-
tion. This is due to the fact that when an infected cell is
part of an infected patch, it already has infected neigh-
bors and therefore has fewer infectable neighbors than
a single infected cell whose neighbors are all infectable.
This results in a smaller effective infection rate in sim-
ulations where initially infected cells are distributed in
larger lumps. The author then explored the effect of tar-
get cell replenishment. In ODE models, target cells are
typically replenished at a fixed rate or at a rate propor-
tional to the number of target cells as a function of cell
division. Beauchemin explored the effects of changing
the replacement rule such that an empty site can only be
replenished by a new target cell if it is in contact with
a dividing uninfected target cell. Screenshots resulting
from both regeneration rules are presented in Figure 1.
As the infection wave spread outward, it left behind
a pool of dead cells, which could only be replenished if
in contact with uninfected cells. This could only happen
once immune cells had detected the infection and began
breaching the infection wave that segregates the dead
cells from the uninfected cells (see Figure 1). This mod-
ification to the model yielded a curve for the fraction of
dead cells over time which closely resembled experimen-
tally observed curves [10, 19] and contrasted with the
sharp and narrow curves obtained with a model where
replacement rate only depends on the number of unin-
fected cells but not on their location.
D. Infection of Cell Layers
Because emerging spatial patterns can have a signif-
icant effect on the development and outcome of a sim-
ulated infection, it is important to define the model in
a manner that is consistent with the true spatial nature
of the real system. For example, two existing ABMs of
HIV [97, 109] are implemented on 2-D square lattices
where each site represents a T cell and the infection
spreads from infected cells to their neighbors. The in-
fection spreads as a wave and under certain conditions,
intricate wave patterns can form. Unfortunately, while
it is true that T cells are tightly packed (as in a lattice)
[6], they are quite motile with velocities of approximately
11 µm/min [71, 75]. It is likely that if the T cells in these
HIV models were motile, these intricate infection wave
patterns would not form.
There are, however, models where a 2-D lattice of
static cells is the best and most accurate representa-
tion. An example of this are in vitro experiments con-
ducted on 2-D cell monolayers [30, 51, 59]. Howat et
al. [51] used data from 2-D Madine-Darby bovine kid-
ney (MDBK) and Vero cell cultures infected with Her-
pes simplex virus 1 (HSV-1) to study the antiviral effect
of interferon β (IFN-β). Their ABM consists of a 2-D
hexagonal lattice where each site represents a target cell
that can either be susceptible, infected, in an antiviral
state, or dead. Because IFN-β diffusion is very fast, it
is taken to be instantaneous and IFN-β is tracked as a
single global variable. Because the experimental cellu-
lar monolayer is overlaid with an agar that impedes viral
diffusion, infection is assumed to spread locally: Virions
are released by an infected cell as a single burst upon cell
death and distributed to the 6 immediate neighbors and
12 next neighbors weighted according to distance. By
comparing the fraction of dead cells over time obtained
experimentally to what their ABM produces, the authors
were able to calibrate their model and determine key pa-
rameters of HSV-1 infection and IFN-β protection. For
example, they found that it takes about 95 hours for the
MDBK monolayer to reach an antiviral state [51]. Once
calibrated, Howat et al. used their model to determine
the dosage of HSV-1 needed to obtain total monolayer
destruction, maximum IFN-β production, or minimum
recovery time. Notably, the authors determined that
the minimum recovery time is obtained for the maxi-
mum boundary length, i.e., when the dead cell plaque
geometry is such that it maximizes the number of cells
in contact with an empty area (a pool of dead cells).
Beyond in vitro experimental systems, there are also in
vivo diseases which can be accurately represented by a 2-
D lattice of non-motile cells. An uncomplicated influenza
infection, i.e., one which infects only the upper lung and
does not degenerate to pneumonia, is a good example.
Beauchemin et al. [10, 14] have taken advantage of this
fact and developed MASyV’s ma immune, a 2-D square
lattice model of influenza A infection [11]. This repre-
sentation is a reasonable description of the true system
because the target of influenza A is the tightly packed
monolayer of cells that line the airways. Additionally,
since influenza virions only bud apically (from the top of
the infected cells) [77] the infection effectively occurs in a
2-D plane. Interestingly, when this model was published
in 2005, it was only the second model ever proposed for
influenza infection in humans; the other one being the 60
parameter ODEmodel with delays proposed by Bocharov
and Romanyukha 20 years earlier [19]. At the time, very
little experimental data on the dynamics of influenza was
available and a spatial model was especially difficult to
justify. Nevertheless, Beauchemin et al. were able to fix
3 of their parameters and set realistic biological bounds
on 6 of the 8 other parameters from information gathered
in the literature. Then, picking parameter values within
these bounds, the authors were able to reproduce a num-
ber of features of influenza infection, for example, that
the peak of infected cells occurs at 48 h and that infection
resolves by day 5± 2. This work was originally intended
to show that the ABM is complex enough to reproduce
the general shape of a response to an uncomplicated viral
infection, and that it yields quantitatively reasonable re-
sults when parameterized for a particular viral infection.
The ABM was later used to study the influence of spa-
6FIG. 1: Effect of the regeneration rule on the infection dynamics. From left to right: (a) using a global rule where dead cells
are replaced at a rate proportional to the total number of uninfected cells; (b) using a local rule where dead cells are only
replaced when an immediate uninfected neighbor is dividing; (c) when using the local rule, dead cells can only be regenerated
once the infection wave has been breached by the immune cells. Using the same infection and death rate, a local regeneration
rule results in a larger number of dead cells but a smaller number of infected cells compared to a non-spatial global rule. The
images are screenshots taken from MASyV’s ma immune client [10, 11] and represent a 2-D tissue patrolled by immune cells
(blue) where each lattice site corresponds to a tissue cell which can either be uninfected (white), dead (black), or in various
stages of infection (green, yellow, red).
tial heterogeneities on the dynamical evolution of a viral
infection [10], as discussed in Section 2.3.
This model also improved our understanding of flu ki-
netics. The model was used to derive values for some
parameters (e.g. replication rate of cytotoxic T lympho-
cytes per infected cell encounter) that were subsequently
employed in other influenza models [25]. The model’s
agreement with the limited available data motivated its
expansion into a more detailed and accurate model of
influenza infection in vitro. In collaboration with exper-
imentalist Dr. Frederick T. Koster, M.D., and Univer-
sity of New Mexico computer scientist Stephanie Forrest,
Beauchemin and others developed an improved version of
the model, MASyV’s ma virions, which accounts for vi-
ral release, dispersion, and clearance [11, 13]. The ABM
consists of a 2-D hexagonal grid representing lung tissue
and on which viral concentrations evolve based on a dis-
cretized version of the diffusion equation. Calibration of
the ABM was accomplished by quantitatively comparing
the ABM’s results with experimental data for fraction of
infected cells, patchiness, and viral concentrations versus
time produced by an in vitro human lung cell monolayer
[13]. The calibration to preliminary data provided an
estimate for the diffusion rate of virions that was 1,000-
fold lower than the natural diffusion expected from the
Stokes-Einstein equation. The calibrated virion diffusion
rate is consistent with virions getting trapped by cell re-
ceptors and mucus [13].
E. Agent-Based Models in Shape Space
The space in which ABMs evolve does not always need
to correspond to 3-D Euclidean space. Another variety
of ABMs of host-pathogen/immune systems are called
shape space models [27, 28, 61, 83, 84, 92, 95, 98]. In
these ABMs, the spatial dimensions represent the gen-
eralized shapes [83] of cell receptors and epitopes, the
parts of antigens recognized by the immune system. The
affinity between a receptor and an epitope is a function
of their distance in shape space [83]. The evolution of
the system in space and time then can be used to rep-
resent the development of an immune response including
receptor variability due to somatic hypermutation, and
the dynamics of clonal expansion and contraction. Typi-
cally, an epitope corresponds to a given location in shape
space and its presence stimulates the activation and pro-
liferation of lymphocytes located at and around that site,
that is, those with a high receptor affinity for that epi-
tope. In modeling viral infections it is also possible to
allow the virus to mutate and evolve its epitopes so as to
avoid immune elimination. Thus, the shape space frame-
work is very flexible and has obvious use in immunologi-
cal modeling.
One shape space model that has had an impact on in-
fluenza research was proposed by Smith et al. [93] in order
to study the efficacy of repeated annual influenza vacci-
nation. Although annual influenza vaccination is recom-
mended for high risk groups, such as infants and the el-
derly, clinical studies of the efficacy of annual vaccination
have lead to conflicting results. One empirical study by
Hoskins et al. [50] suggested that during some flu sea-
sons patients given repeated annual vaccinations had less
protection that first-time vaccinees, while another study
suggested that repeated annual vaccination did in fact of-
fer long-term continual protection [54]. Smith et al. [93]
showed that differences in the antigenic distance (i.e. the
distance in shape space) between the vaccine strain and
the circulating influenza strain in both studies, which
were conducted in different years, could account for the
observed discrepancies in the results. In particular, they
showed that a first vaccine will negatively interfere with
the protection potentially afforded by a second vaccine
when the two vaccine strains are close in shape space.
This is because the first vaccination raises antibodies
that by cross-reactivity can partially eliminate the sec-
7ond vaccine. Using an ABM that followed the dynamics
of a broad array of B cells and antibodies for the vaccine
epitopes, Smith et al. [93] were able to show in a quanti-
tative manner how the model could explain the available
experimental data on the efficacy of repeated vaccination.
Further, the idea of monitoring the antigenic distance in
shape space between flu strains has proved to be a valu-
able approach in studying influenza evolution [94] and is
now a factor in the World Health Organization’s bian-
nual decision making process for selecting which vaccine
strains to include in the seasonal influenza vaccine [91].
F. The Role of Agent-Based Models in Multiscale
Systems
Biological systems naturally span multiple time and
length scale hierarchies. Time and spatial scales can
range from 10−2 seconds and 10−9 meters during gene
transcription and protein production at the molecular
level to 106 seconds and up to several meters at the level
of the whole organism [52, 88]. However, experimental
investigations and the data generated focus on specific
mechanisms relegated to isolated time or length scales
and must be translated between biological scales. A mul-
tiscale approach to modeling biological systems is crucial
to developing realistic and relevant models capable of pre-
dicting complex biological phenomena.
Bridging multiple scales is a formidable modeling chal-
lenge. Because ABMs are constructed by considering
the behaviors of individual system components and can
be developed for each biological subsystem or hierarchy,
they are also naturally well suited for linking these dif-
ferent models together. For example, merging ABMs
focusing on different biological scales has been used to
translate the results of and facilitate collaboration be-
tween experimental groups working on various aspects
of the acute inflammatory response [3]. In this work, a
group of agent based models were developed to simulate
intracellular signal transduction pathways that were then
incorporated into ABMs for different cell types. Subse-
quently, these cellular models were integrated to simulate
tissue and whole organ function during the acute inflam-
matory response.
Another modeling technique that has emerged in re-
sponse to the computational challenge presented by mul-
tiple scales integrates differential equation models with
ABMs to couple the dynamics occurring on different time
and length scales [1, 9, 53, 56, 80, 108]. This technique
has been applied to the development of models describing
tumor growth, a complex biological system with impor-
tant clinical applications [1, 53, 108]. In Jiang et al. [53],
a three-dimensional model of avascular tumor growth was
developed that spans three distinct scales. A type of
ABM, called a lattice Monte Carlo model, is used to de-
scribe tumor cell growth, adhesion, and viability. These
cell dynamics are regulated at the intracellular level by a
Boolean network for protein expression that controls the
cell cycle. At the extracellular level, nutrients, metabolic
waste, and growth factor and inhibitory chemical concen-
trations are described by a system of partial differential
equations. Growth curve measurements and measure-
ments of the size of the proliferating rim and necrotic core
regions from simulated tumors agree with the quantita-
tive results obtained from tumor spheroid experiments.
This model predicts what environmental conditions tu-
mor cells require for survival, and the molecular weight
of potential growth promoters and inhibitors regulating
tumor cell viability. As demonstrated by these results,
validated models of biological systems provide new bi-
ological insights, can be used for prediction, and guide
future experimental pursuits. Looking forward, coupling
tumor growth models with agent-based and cell-based
models of angiogenesis [9, 80] and the immune system
response against the tumor will be a major step towards
the development of an integrated systems approach to
modeling tumor growth and cancer invasion and towards
the ultimate goal of predicting the effects of novel cancer
and anti-angiogenic therapies.
G. Improved Experimental Data Fueling Advances
in Modeling
Models of any type can only be as good as the data
used to develop, calibrate and confirm them. Fortu-
nately, new experimental techniques are allowing access
to unprecedented amounts of data, but also to novel types
of data. Because ABMs are spatial models they require
spatial data: a rare commodity. High resolution spa-
tial data is especially important given that localized spa-
tial effects can have an important impact on the result-
ing dynamics, as mentioned above. The recent appli-
cation of two-photon microscopy to in situ and in vivo
imaging of mice lymph nodes has determined trajectories
of individual T cells as they move within lymph nodes
[6, 42, 74, 75, 76]. This new technique has revealed that
T cell motion in lymph nodes occurs largely as a result
of the cells crawling along fibers of the fibroblastic retic-
ular cell network [6]. Additionally, examination of these
trajectories has shown that the end-to-end distance that
T cells travel increases approximately linearly with the
square root of time, suggesting that the movement of T
cell over long distances can be described by a random
walk rather than motility guided by chemotaxis. These
new data have facilitated the elaboration of models for
the movement of T cells within lymph nodes: some sim-
ple [12] and some more detailed [15, 72].
The model by Beauchemin et al. [12] was a simple
model where a T cell moves in a straight line at constant
speed vfree for a time tfree, then pauses for a time tpause
as it reorganizes its intracellular machinery allowing it
to turn. It then picks a new direction, and undergoes
another free run. Comparing simulations against exper-
imental data yielded a mean free path of approximately
38 µm, which is about twice the distance between inter-
8sections in the fibroblastic reticular cell network, which
averages 17± 7 µm. From this, the authors concluded
that when coming to a fiber intersection, a T cell will
turn roughly 50% of the time, and 50% of the time it will
continue along its original fiber.
The Meyer-Hermann and Maini model [72] offers a
more detailed description of the active crawling exhib-
ited by both B and T cells. This model is a 2-D cellular
Potts model [43, 44] where a B or T cell is represented
by a group of neighboring lattice sites. The lattice sites
that make up the lymphocyte are moved individually but
their movements are constrained to maintain a constant
cell volume and to respect the general direction chosen
for active movement. The model yielded a distribution
for the velocities of B and T cells that agreed impressively
well with velocities obtained experimentally [72].
More recently, Beltman et al. [15] proposed a 3-D
rather than a 2-D cellular Potts model, which also repre-
sented lymphocytes as a collection of neighboring lattice
sites. The authors investigated the possibility that motil-
ity patterns observed for T cells and dendritic cells are a
result of the anatomical structure of lymph nodes, rather
than an intrinsic characteristic of the cells’ motility. In-
deed, they found that by restraining T cell movement
using the constraints imposed by anatomical barriers in
lymph nodes, the model can account for all character-
istics of the experimental observations. In particular,
they showed that lymph node anatomy can explain the
large velocity fluctuations seen experimentally for T cells.
Further, they found that as a result of the obstacles, T
cells tend to organize into small, highly dynamic streams
and provide experimental evidence to support these new
findings. Finally, using their model, they were able to
predict that dendritic cells would be able to contact ap-
proximately 2,000 different T cells per hour while T cells
could contact roughly 100 dendritic cells per hour [15].
H. Sensitivity and Uncertainty Analysis in
Modeling and Prediction
Because ABMs consist of several thousand lines of
code, it can often be just as complicated to understand
the model as it is to understand the real system. In gen-
eral, as the system grows in complexity, the number of pa-
rameters that must be estimated also increases. Parame-
ter estimation introduces uncertainty into the system due
to experimental error, differences in experimental assays,
or error from data fitting techniques. Moreover, when the
number of agents is large and their interactions numer-
ous and complicated, it can become difficult to extract or
isolate the key processes responsible for a given outcome.
In their paper proposing an ABM of M. tuberculosis in-
fection, Segovia-Juarez, Ganguli, and Kirschner [88] use
a simple and efficient way of analyzing their results by
performing a sensitivity and uncertainty analysis of the
model’s parameters. The authors picked 12 of the 27 pa-
rameters of their model and investigated their effect on
the growth of tuberculosis granulomas. Using the num-
ber of extracellular bacterium and the granuloma size as
outcome variables, they mapped out the parameter space
using the Latin hypercube sampling method and quan-
tified the sensitivity of their model to these parameters
using partial rank correlation coefficients on each param-
eter set. This type of analysis quantifies the importance
and impact of each parameter on the outcome variables.
Their analysis revealed that the intracellular growth rate
of the bacteria is strongly and positively correlated with
the number of extracellular bacteria at early times of the
infection and at much later times post-infection, and neg-
atively correlated at intermediate times. This suggests
that at low bacterial levels, a large intracellular bacteria
growth rate is critical to infection, while a small growth
rate seems necessary to generate larger lasting granulo-
mas. This is one example of how simulation and analysis
can be coupled to provide insights into and enhance our
understanding of the dynamics of disease (see [18, 66] for
a more complete review of these analytic techniques).
III. DISCUSSION
Agent-based models have inspired significant interest
through their visual appeal and because the languages
used to describe the model and the natural system are
very similar. Computational advances are making pos-
sible the use of ABMs to describe whole systems arising
not only in the human immune system, which has been
the focus of this article, but also in financial markets
[37, 47, 99, 101], the spread of epidemics [29, 100], cancer
dynamics [1, 53, 65, 108], and the threat of bio-warfare
[20] to name just a few. In addition, ABMs have engaged
experimentalists and have helped facilitate their increas-
ing involvement in modeling. Here, we have presented a
limited survey of ABMs in the context of host-pathogen
dynamics. This survey is in no way exhaustive, but is
meant to highlight the novel and original modeling ap-
proaches applied by researchers and the contributions to
our knowledge of specific diseases and immune mecha-
nisms.
ABMs are only one of a number of modeling tech-
niques that could be applied to describe a particular
system. The choice of model to employ is guided by
multiple factors including the questions that one wishes
to answer, the assumptions that can be made, param-
eter availability, and computational expense. Choos-
ing agent-based modeling is not without cost or con-
sequence. ABMs tend to require a larger number of
parameters than both ODE models and their spatially-
continuous partial differential equation analogs. Until
experimental assays capable of measuring relevant ex-
perimental data catch up with the needs and complexity
of model calibration, ODEs are sometimes the only vi-
able modeling option. An important weakness of ABMs
arises in the context of sharing and comparing results.
At worst, a partial differential equation model with de-
9lays will consist of a large and complicated set of equa-
tions, but that can be written down in an unambigu-
ous manner. In contrast, an ABM consists of many
lines of codes which could be in any variety of program-
ming languages, and its translation into words can over-
look very important details of its implementation that
are crucial to reproducing its results. This is a prob-
lem that researchers utilizing ABMs need to pay more
attention to. Establishing a permanent home for any
computer model developed and a static version corre-
sponding to the exact state of the program used for pub-
lished results are important first steps. Software reposi-
tories like SourceForge.net (http://sourceforge.net)
and freshmeat (http://freshmeat.net) provide such
services free of cost.
As with any modeling approach, ABMs need to ad-
here to the principles of scientific rigor. For an ABM to
be useful to understanding the mechanisms of the sys-
tem, it needs to convincingly relate to it. Models need to
be calibrated and researchers should confirm that their
parameter values are within physically relevant ranges.
Toward this end, it is helpful to provide a sensitivity
analysis of the parameters to identify key parameters
and to fully grasp the consequences of parameter uncer-
tainty and variability on the observed outcomes. Mod-
elers should also make every effort possible to quantita-
tively validate the results of their simulations with in-
dependent experiments or with reports in the literature,
using data different from those that were used for model
calibration. Finally, and perhaps most importantly, mod-
els should strive to make experimentally verifiable predic-
tions. Once verified, such predictions will establish that
the model realistically captures some aspects of the sys-
tem. Further, models validated in this way may offer
new perspectives, provide a framework for formulating
and testing hypotheses, and may suggest important new
experiments.
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